Alternative flu vaccine should reduce medical costs and save lives

(Taylor & Francis Group) A study just published in Human Vaccines & Immunotherapeutics suggests that an alternative vaccine might bring clinical benefits and cost savings if used on a large scale when compared to the one currently in widest use